A citation-based method for searching scientific literature

Anda-Alexandra Calinescu, McKenzie C Kauss, Zain Sultan, Wajd N Al-Holou, Sue K O'Shea. CNS Oncol 2021
Times Cited: 3







List of co-cited articles
19 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
David Rufino-Ramos, Patrícia R Albuquerque, Vitor Carmona, Rita Perfeito, Rui Jorge Nobre, Luis Pereira de Almeida. J Control Release 2017
163
66

Current state of immunotherapy for glioblastoma.
Michael Lim, Yuanxuan Xia, Chetan Bettegowda, Michael Weller. Nat Rev Clin Oncol 2018
473
66

MR imaging tracking of inflammation-activatable engineered neutrophils for targeted therapy of surgically treated glioma.
Meiying Wu, Haixian Zhang, Changjun Tie, Chunhong Yan, Zhiting Deng, Qian Wan, Xin Liu, Fei Yan, Hairong Zheng. Nat Commun 2018
79
66

Mesenchymal stem cells loaded with paclitaxel-poly(lactic-co-glycolic acid) nanoparticles for glioma-targeting therapy.
Xiaoling Wang, Jianqing Gao, Xumei Ouyang, Junbo Wang, Xiaoyi Sun, Yuanyuan Lv. Int J Nanomedicine 2018
51
66

Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence.
Jingwei Xue, Zekai Zhao, Lei Zhang, Lingjing Xue, Shiyang Shen, Yajing Wen, Zhuoyuan Wei, Lu Wang, Lingyi Kong, Hongbin Sun,[...]. Nat Nanotechnol 2017
355
66

NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo.
Gang Jia, Yong Han, Yanli An, Yinan Ding, Chen He, Xihui Wang, Qiusha Tang. Biomaterials 2018
191
66

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.
Quinn T Ostrom, Nirav Patil, Gino Cioffi, Kristin Waite, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2020
498
66

Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity.
Jessian L Munoz, Sarah A Bliss, Steven J Greco, Shakti H Ramkissoon, Keith L Ligon, Pranela Rameshwar. Mol Ther Nucleic Acids 2013
325
66

Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.
Olivier L Chinot, Wolfgang Wick, Warren Mason, Roger Henriksson, Frank Saran, Ryo Nishikawa, Antoine F Carpentier, Khe Hoang-Xuan, Petr Kavan, Dana Cernea,[...]. N Engl J Med 2014
66

Trojan horse monocyte-mediated delivery of conjugated polymer nanoparticles for improved photodynamic therapy of glioblastoma.
Luis E Ibarra, Lucía Beaugé, Nuria Arias-Ramos, Viviana A Rivarola, Carlos A Chesta, Pilar López-Larrubia, Rodrigo E Palacios. Nanomedicine (Lond) 2020
18
66

The impact of Mesenchymal Stem Cells and their secretome as a treatment for gliomas.
E D Gomes, J Vieira de Castro, B M Costa, A J Salgado. Biochimie 2018
16
66

Effect of canine mesenchymal stromal cells loaded with paclitaxel on growth of canine glioma and human glioblastoma cell lines.
A Bonomi, E Ghezzi, L Pascucci, M Aralla, V Ceserani, L Pettinari, V Coccè, A Guercio, G Alessandri, E Parati,[...]. Vet J 2017
14
66

Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2.
Lei Yu, Si Gui, Yawei Liu, Xiaoyu Qiu, Guozhong Zhang, Xi'an Zhang, Jun Pan, Jun Fan, Songtao Qi, Binghui Qiu. Aging (Albany NY) 2019
39
66

Exosomes derived from microRNA-512-5p-transfected bone mesenchymal stem cells inhibit glioblastoma progression by targeting JAG1.
Tengfeng Yan, Miaojing Wu, Shigang Lv, Qing Hu, Wenhua Xu, Ailiang Zeng, Kai Huang, Xingen Zhu. Aging (Albany NY) 2021
7
66

An In Vitro Comparison of Anti-Tumoral Potential of Wharton's Jelly and Bone Marrow Mesenchymal Stem Cells Exhibited by Cell Cycle Arrest in Glioma Cells (U87MG).
Nazneen Aslam, Elham Abusharieh, Duaa Abuarqoub, Dana Alhattab, Hanan Jafar, Walhan Alshaer, Razan J Masad, Abdalla S Awidi. Pathol Oncol Res 2021
3
66

Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas.
Qing Zhang, Wei Xiang, Dong-Ye Yi, Bing-Zhou Xue, Wan-Wan Wen, Ahmed Abdelmaksoud, Nan-Xiang Xiong, Xiao-Bing Jiang, Hong-Yang Zhao, Peng Fu. Stem Cell Res Ther 2018
38
66

Bone Marrow-Derived Mesenchymal Stem Cells Differentially Affect Glioblastoma Cell Proliferation, Migration, and Invasion: A 2D-DIGE Proteomic Analysis.
Shenjie Li, Wei Xiang, Junjie Tian, Haorun Wang, Shuiwang Hu, Ke Wang, Ligang Chen, Changren Huang, Jie Zhou. Biomed Res Int 2021
6
66

hUC-MSCs secreted exosomes inhibit the glioma cell progression through PTENP1/miR-10a-5p/PTEN pathway.
S-C Hao, H Ma, Z-F Niu, S-Y Sun, Y-R Zou, H-C Xia. Eur Rev Med Pharmacol Sci 2019
18
66

Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas.
Frederick M Lang, Anwar Hossain, Joy Gumin, Eric N Momin, Yuzaburo Shimizu, Dan Ledbetter, Tal Shahar, Shinji Yamashita, Brittany Parker Kerrigan, Juan Fueyo,[...]. Neuro Oncol 2018
109
66

Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
Reatul Karim, Claudio Palazzo, Brigitte Evrard, Geraldine Piel. J Control Release 2016
132
33

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
33

Cancer stem cells in glioblastoma.
Justin D Lathia, Stephen C Mack, Erin E Mulkearns-Hubert, Claudia L L Valentim, Jeremy N Rich. Genes Dev 2015
834
33

Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2.
Guo-Zhong Yi, Guanglong Huang, Manlan Guo, Xi'an Zhang, Hai Wang, Shengze Deng, Yaomin Li, Wei Xiang, Ziyang Chen, Jun Pan,[...]. Brain 2019
57
33

Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.
Jann N Sarkaria, Leland S Hu, Ian F Parney, Deanna H Pafundi, Debra H Brinkmann, Nadia N Laack, Caterina Giannini, Terence C Burns, Sani H Kizilbash, Janice K Laramy,[...]. Neuro Oncol 2018
239
33

Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium.
Giorgio Seano, Hadi T Nia, Kyrre E Emblem, Meenal Datta, Jun Ren, Shanmugarajan Krishnan, Jonas Kloepper, Marco C Pinho, William W Ho, Mitrajit Ghosh,[...]. Nat Biomed Eng 2019
60
33

The cellular origin for malignant glioma and prospects for clinical advancements.
Hui Zong, Roel G W Verhaak, Peter Canoll. Expert Rev Mol Diagn 2012
103
33

Photothermal treatment of glioma; an in vitro study of macrophage-mediated delivery of gold nanoshells.
Seung-Kuk Baek, Amani Riad Makkouk, Tatiana Krasieva, Chung-Ho Sun, Steen J Madsen, Henry Hirschberg. J Neurooncol 2011
97
33

ABC transporters as mediators of drug resistance and contributors to cancer cell biology.
Jamie I Fletcher, Rebekka T Williams, Michelle J Henderson, Murray D Norris, Michelle Haber. Drug Resist Updat 2016
213
33

Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors.
Mathilde Roger, Anne Clavreul, Marie-Claire Venier-Julienne, Catherine Passirani, Laurence Sindji, Paul Schiller, Claudia Montero-Menei, Philippe Menei. Biomaterials 2010
146
33

Human Cancer Cell Membrane-Coated Biomimetic Nanoparticles Reduce Fibroblast-Mediated Invasion and Metastasis and Induce T-Cells.
Jiefu Jin, Balaji Krishnamachary, James D Barnett, Samit Chatterjee, Di Chang, Yelena Mironchik, Flonne Wildes, Elizabeth M Jaffee, Sridhar Nimmagadda, Zaver M Bhujwalla. ACS Appl Mater Interfaces 2019
50
33

Maximum safe resection of glioblastoma multiforme.
Michel Lacroix, Steven A Toms. J Clin Oncol 2014
18
33

Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes.
Gyeungyun Kim, Minkyung Kim, Youngki Lee, Jung Woo Byun, Do Won Hwang, Minhyung Lee. J Control Release 2020
76
33


Emerging insights into barriers to effective brain tumor therapeutics.
Graeme F Woodworth, Gavin P Dunn, Elizabeth A Nance, Justin Hanes, Henry Brem. Front Oncol 2014
93
33

Cell-mediated targeting drugs delivery systems.
Hongli Yu, Zhihong Yang, Fei Li, Lisa Xu, Yong Sun. Drug Deliv 2020
14
33

Cell Membrane Coating Nanotechnology.
Ronnie H Fang, Ashley V Kroll, Weiwei Gao, Liangfang Zhang. Adv Mater 2018
469
33

Combination antitumor therapy with targeted dual-nanomedicines.
Wenbing Dai, Xiaoyou Wang, Ge Song, Tongzhou Liu, Bing He, Hua Zhang, Xueqing Wang, Qiang Zhang. Adv Drug Deliv Rev 2017
70
33

The 2007 WHO classification of tumours of the central nervous system.
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues. Acta Neuropathol 2007
33

Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials.
Yung-Hao Tsou, Xue-Qing Zhang, He Zhu, Sahla Syed, Xiaoyang Xu. Small 2017
75
33

Highly penetrative liposome nanomedicine generated by a biomimetic strategy for enhanced cancer chemotherapy.
Yali Jia, Zonghai Sheng, Dehong Hu, Fei Yan, Mingting Zhu, Guanhui Gao, Pan Wang, Xin Liu, Xiaobing Wang, Hairong Zheng. Biomater Sci 2018
21
33

Redox-Responsive Dipeptide Nanostructures toward Targeted Cancer Therapy.
Sonika Chibh, Avneet Kour, Nitin Yadav, Pankaj Kumar, Pratik Yadav, Virander Singh Chauhan, Jiban Jyoti Panda. ACS Omega 2020
15
33

Cell Membrane-Coated Magnetic Nanocubes with a Homotypic Targeting Ability Increase Intracellular Temperature due to ROS Scavenging and Act as a Versatile Theranostic System for Glioblastoma Multiforme.
Christos Tapeinos, Francesca Tomatis, Matteo Battaglini, Aitor Larrañaga, Attilio Marino, Iker Aguirrezabal Telleria, Makis Angelakeris, Doriana Debellis, Filippo Drago, Francesca Brero,[...]. Adv Healthc Mater 2019
17
33

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
33

Exploiting macrophages as targeted carrier to guide nanoparticles into glioma.
Liang Pang, Jing Qin, Limei Han, Wenjie Zhao, Jianming Liang, Zhongyi Xie, Pei Yang, Jianxin Wang. Oncotarget 2016
67
33


Biodegradable polymers: an update on drug delivery in bone and cartilage diseases.
Ana Cláudia Lima, Helena Ferreira, Rui L Reis, Nuno M Neves. Expert Opin Drug Deliv 2019
14
33

European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas.
Michael Weller, Martin van den Bent, Jörg C Tonn, Roger Stupp, Matthias Preusser, Elizabeth Cohen-Jonathan-Moyal, Roger Henriksson, Emilie Le Rhun, Carmen Balana, Olivier Chinot,[...]. Lancet Oncol 2017
554
33

Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment.
Ruixiang Li, Yuwei He, Shuya Zhang, Jing Qin, Jianxin Wang. Acta Pharm Sin B 2018
134
33

Nanoparticle-Based Therapeutics for Brain Injury.
Vimala N Bharadwaj, Duong T Nguyen, Vikram D Kodibagkar, Sarah E Stabenfeldt. Adv Healthc Mater 2018
52
33

Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.
Nicolas Bertrand, Jun Wu, Xiaoyang Xu, Nazila Kamaly, Omid C Farokhzad. Adv Drug Deliv Rev 2014
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.